Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 67

1.

Changing Trends in Treatment of Acute Mania: Experience of a Tertiary Centre Over a Decade.

Arıkan MK, Poyraz CA, Baş A, Sağlam NG, Batun GC, Gültekin G, Poyraz BÇ.

Psychiatr Q. 2016 Jun;87(2):305-13. doi: 10.1007/s11126-015-9388-9.

PMID:
26220636
2.

The psychopharmacology algorithm project at the Harvard South Shore Program: an algorithm for acute mania.

Mohammad O, Osser DN.

Harv Rev Psychiatry. 2014 Sep-Oct;22(5):274-94. doi: 10.1097/HRP.0000000000000018. Review.

PMID:
25188733
3.

Prescription patterns of psychotropic medications for the treatment of psychotic disorders in the largest mental health institutions of Uganda.

Rukat A, Musisi S, Ströhle A, Mundt AP.

J Clin Psychopharmacol. 2014 Oct;34(5):571-6. doi: 10.1097/JCP.0000000000000166.

PMID:
24943390
4.

Antipsychotic drugs, mood stabilizers, and risk of pneumonia in bipolar disorder: a nationwide case-control study.

Yang SY, Liao YT, Liu HC, Chen WJ, Chen CC, Kuo CJ.

J Clin Psychiatry. 2013 Jan;74(1):e79-86. doi: 10.4088/JCP.12m07938.

PMID:
23419234
5.

How assess drugs in the treatment of acute bipolar mania?

Bourin M, Thibaut F.

Front Pharmacol. 2013 Jan 29;4:4. doi: 10.3389/fphar.2013.00004. eCollection 2013.

6.

A larval zebrafish model of bipolar disorder as a screening platform for neuro-therapeutics.

Ellis LD, Soanes KH.

Behav Brain Res. 2012 Aug 1;233(2):450-7. doi: 10.1016/j.bbr.2012.05.043. Epub 2012 Jun 5.

PMID:
22677277
7.

Modulation of antipsychotic-induced extrapyramidal side effects by medications for mood disorders.

Tatara A, Shimizu S, Shin N, Sato M, Sugiuchi T, Imaki J, Ohno Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Aug 7;38(2):252-9. doi: 10.1016/j.pnpbp.2012.04.008. Epub 2012 Apr 17.

PMID:
22542492
8.

Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.

Katagiri H, Takita Y, Tohen M, Higuchi T, Kanba S, Takahashi M.

Curr Med Res Opin. 2012 May;28(5):701-13. doi: 10.1185/03007995.2012.666961. Epub 2012 Apr 10.

PMID:
22356118
9.

Oxcarbazepine for acute affective episodes in bipolar disorder.

Vasudev A, Macritchie K, Vasudev K, Watson S, Geddes J, Young AH.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD004857. doi: 10.1002/14651858.CD004857.pub2. Review.

PMID:
22161387
10.

Refractoriness in bipolar disorder: definitions and evidence-based treatment.

Fountoulakis KN.

CNS Neurosci Ther. 2012 Mar;18(3):227-37. doi: 10.1111/j.1755-5949.2011.00259.x. Epub 2011 Aug 2. Review.

PMID:
22070611
11.

Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis.

Cipriani A, Barbui C, Salanti G, Rendell J, Brown R, Stockton S, Purgato M, Spineli LM, Goodwin GM, Geddes JR.

Lancet. 2011 Oct 8;378(9799):1306-15. doi: 10.1016/S0140-6736(11)60873-8. Epub 2011 Aug 16. Review.

PMID:
21851976
12.

Stevens-Johnson syndrome progressing to toxic epidermal necrolysis with haloperidol and carbamazepine combination.

Kumar A, Sarkar S, Praharaj SK, Akhtar S, Diwakar M.

Ind Psychiatry J. 2011 Jul;20(2):131-3. doi: 10.4103/0972-6748.102517.

13.

Spontaneously Hypertensive Rats (SHR) present deficits in prepulse inhibition of startle specifically reverted by clozapine.

Levin R, Calzavara MB, Santos CM, Medrano WA, Niigaki ST, Abílio VC.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1748-52. doi: 10.1016/j.pnpbp.2011.06.003. Epub 2011 Jun 13.

14.

Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials.

Yildiz A, Vieta E, Leucht S, Baldessarini RJ.

Neuropsychopharmacology. 2011 Jan;36(2):375-89. doi: 10.1038/npp.2010.192. Epub 2010 Oct 27. Review.

15.

Bipolar disorder and tuberous sclerosis complex: is it a mere coincidence?

Haq MZ, Dubey I, Khess CR, Das U, Kumar R.

CNS Spectr. 2009 Nov;14(11):643-7.

PMID:
20173689
16.

Early effects of mood stabilizers on the Akt/GSK-3beta signaling pathway and on cell survival and proliferation.

Aubry JM, Schwald M, Ballmann E, Karege F.

Psychopharmacology (Berl). 2009 Aug;205(3):419-29. doi: 10.1007/s00213-009-1551-2. Epub 2009 May 14.

PMID:
19440698
17.

Interactions between magnesium and psychotropic drugs.

Nechifor M.

Magnes Res. 2008 Jun;21(2):97-100. Review.

18.

Acute and long-term treatment of mania.

Vieta E, Sanchez-Moreno J.

Dialogues Clin Neurosci. 2008;10(2):165-79. Review.

19.

Neuroleptic drugs revert the contextual fear conditioning deficit presented by spontaneously hypertensive rats: a potential animal model of emotional context processing in schizophrenia?

Calzavara MB, Medrano WA, Levin R, Kameda SR, Andersen ML, Tufik S, Silva RH, Frussa-Filho R, Abílio VC.

Schizophr Bull. 2009 Jul;35(4):748-59. doi: 10.1093/schbul/sbn006. Epub 2008 Feb 16.

20.

Adjunctive treatment of acute mania: a clinical overview.

Sachs GS, Gardner-Schuster EE.

Acta Psychiatr Scand Suppl. 2007;(434):27-34. Review.

PMID:
17688460

Supplemental Content

Loading ...
Support Center